23andMe Holding Co. (NASDAQ:ME) Short Interest Update

23andMe Holding Co. (NASDAQ:ME) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 1,700,000 shares, an increase of 22.3% from the February 13th total of 1,390,000 shares. Based on an average daily trading volume, of 299,500 shares, the short-interest ratio is currently 5.7 days. Approximately 10.7% of the company’s stock are sold short.

23andMe Stock Down 3.7 %

Shares of ME opened at $1.84 on Thursday. 23andMe has a twelve month low of $1.34 and a twelve month high of $12.76. The company has a market capitalization of $49.36 million, a P/E ratio of -0.12 and a beta of 1.19. The firm has a 50 day moving average of $2.64 and a 200 day moving average of $4.01.

23andMe (NASDAQ:ME) last released its quarterly earnings results on Tuesday, January 28th. The company reported ($1.02) earnings per share (EPS) for the quarter. 23andMe had a negative return on equity of 170.07% and a negative net margin of 183.39%.

Institutional Trading of 23andMe

Several large investors have recently added to or reduced their stakes in ME. FNY Investment Advisers LLC bought a new position in 23andMe in the 4th quarter worth $26,000. Leavell Investment Management Inc. bought a new position in shares of 23andMe during the 4th quarter valued at approximately $32,000. MassMutual Private Wealth & Trust FSB purchased a new stake in 23andMe in the 4th quarter worth approximately $40,000. Virtu Financial LLC bought a new stake in 23andMe during the 4th quarter worth approximately $49,000. Finally, Geode Capital Management LLC lifted its holdings in 23andMe by 0.7% during the third quarter. Geode Capital Management LLC now owns 4,246,093 shares of the company’s stock valued at $1,476,000 after purchasing an additional 28,252 shares in the last quarter. 36.10% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of 23andMe in a research note on Friday, March 7th.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.